DE69709407T2 - Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen - Google Patents

Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen

Info

Publication number
DE69709407T2
DE69709407T2 DE69709407T DE69709407T DE69709407T2 DE 69709407 T2 DE69709407 T2 DE 69709407T2 DE 69709407 T DE69709407 T DE 69709407T DE 69709407 T DE69709407 T DE 69709407T DE 69709407 T2 DE69709407 T2 DE 69709407T2
Authority
DE
Germany
Prior art keywords
sugar
indolopyrrolocarbazoles
derivatives
cytotoxic amino
sugar derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69709407T
Other languages
English (en)
Other versions
DE69709407D1 (de
Inventor
George Saulnier
Neelakantan Balasubramanian
Bertil Frennesson
Laurent R St
R Langley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE69709407D1 publication Critical patent/DE69709407D1/de
Publication of DE69709407T2 publication Critical patent/DE69709407T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials
DE69709407T 1996-08-22 1997-08-21 Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen Expired - Fee Related DE69709407T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2465796P 1996-08-22 1996-08-22
PCT/US1997/014738 WO1998007433A1 (en) 1996-08-22 1997-08-21 Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles

Publications (2)

Publication Number Publication Date
DE69709407D1 DE69709407D1 (de) 2002-01-31
DE69709407T2 true DE69709407T2 (de) 2002-05-29

Family

ID=21821733

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69709407T Expired - Fee Related DE69709407T2 (de) 1996-08-22 1997-08-21 Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen

Country Status (20)

Country Link
EP (1) EP0971717B1 (de)
JP (1) JP2000516250A (de)
KR (1) KR100450034B1 (de)
CN (1) CN1097460C (de)
AT (1) ATE210988T1 (de)
AU (1) AU710669B2 (de)
BR (1) BR9711306A (de)
CY (1) CY2261B1 (de)
DE (1) DE69709407T2 (de)
DK (1) DK0971717T3 (de)
ES (1) ES2169414T3 (de)
HK (1) HK1024177A1 (de)
HU (1) HUP9903931A3 (de)
IL (1) IL127918A0 (de)
NO (1) NO312071B1 (de)
NZ (1) NZ333536A (de)
PL (1) PL187205B1 (de)
PT (1) PT971717E (de)
RU (1) RU2167880C2 (de)
WO (1) WO1998007433A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US6127401A (en) 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6841567B1 (en) 1999-02-12 2005-01-11 Cephalon, Inc. Cyclic substituted fused pyrrolocarbazoles and isoindolones
US6399780B1 (en) 1999-08-20 2002-06-04 Cephalon, Inc. Isomeric fused pyrrolocarbazoles and isoindolones
US7122679B2 (en) * 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
US6630500B2 (en) 2000-08-25 2003-10-07 Cephalon, Inc. Selected fused pyrrolocarbazoles
US6610727B2 (en) * 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6653290B2 (en) * 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6555677B2 (en) * 2000-10-31 2003-04-29 Merck & Co., Inc. Phase transfer catalyzed glycosidation of an indolocarbazole
JP2004534006A (ja) * 2001-03-22 2004-11-11 ブリストル−マイヤーズ　スクイブ　カンパニー インドロピロロカルバゾール化合物のトポイソメラーゼｉ選択的細胞毒シュガー誘導体
WO2005010018A1 (ja) * 2003-07-24 2005-02-03 Banyu Pharmaceutical Co., Ltd. 結晶形態の６−ｎ−ピリジルメチルアミノインドロカルバゾール化合物
WO2005010017A1 (ja) * 2003-07-24 2005-02-03 Banyu Pharmaceutical Co., Ltd インドロピロロカルバゾール誘導体及び抗腫瘍剤
US7241779B2 (en) 2003-12-23 2007-07-10 Cephalon, Inc. Fused pyrrolocarbazoles
US7169802B2 (en) 2003-12-23 2007-01-30 Cephalon, Inc. Fused pyrrolocarbazoles
DE102004025726B4 (de) 2004-05-26 2006-07-06 Roder, Hanno, Dr. Verwendung eines spezifischen K252a-Derivats zur Verhinderung oder Behandlung der Alzheimerschen Krankheit
CA2672650C (en) * 2006-12-14 2015-09-08 Tautatis, Inc. Compositions and methods for the treatment of cancer
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
CN103965204B (zh) 2008-11-19 2016-09-07 赛福伦公司 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式
RU2557554C1 (ru) * 2014-09-09 2015-07-27 Федеральное государственное бюджетное учреждение "Российский онкологический научный центр имени Н.Н. Блохина" Российской академии медицинских наук (ФГБУ "РОНЦ им. Н.Н. Блохина" РАМН) Производные индолокарбазолов, блокирующие васкулогенную мимикрию в опухоли
CN105198785B (zh) * 2015-09-29 2018-08-21 浙江工业大学 一种顺丁烯二酰亚胺类化合物及其制备与应用
CN112739345A (zh) 2017-11-06 2021-04-30 斯奈普生物公司 Pim激酶抑制剂组合物，方法和其用途
CN109970822B (zh) * 2017-12-27 2023-03-28 上海科胜药物研发有限公司 一种合成埃格列净中间体的制备方法
CN112457235B (zh) * 2020-12-02 2023-04-25 烟台凯博医药科技有限公司 一种7-甲基吲哚的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
WO1996004293A1 (fr) * 1994-08-02 1996-02-15 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazoles antitumoraux

Also Published As

Publication number Publication date
NO990789L (no) 1999-02-19
IL127918A0 (en) 1999-11-30
BR9711306A (pt) 1999-08-17
WO1998007433A1 (en) 1998-02-26
ES2169414T3 (es) 2002-07-01
AU4155897A (en) 1998-03-06
PL187205B1 (pl) 2004-06-30
NO312071B1 (no) 2002-03-11
NO990789D0 (no) 1999-02-19
HUP9903931A2 (hu) 2000-03-28
KR20000068225A (ko) 2000-11-25
DK0971717T3 (da) 2002-03-25
NZ333536A (en) 1999-10-28
AU710669B2 (en) 1999-09-23
JP2000516250A (ja) 2000-12-05
PL331709A1 (en) 1999-08-02
CN1228704A (zh) 1999-09-15
EP0971717A1 (de) 2000-01-19
KR100450034B1 (ko) 2004-09-24
ATE210988T1 (de) 2002-01-15
DE69709407D1 (de) 2002-01-31
EP0971717A4 (de) 2000-04-12
PT971717E (pt) 2002-06-28
CN1097460C (zh) 2003-01-01
CY2261B1 (en) 2003-07-04
HK1024177A1 (en) 2000-10-05
EP0971717B1 (de) 2001-12-19
HUP9903931A3 (en) 2000-09-28
RU2167880C2 (ru) 2001-05-27

Similar Documents

Publication Publication Date Title
DE69709407D1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE231872T1 (de) Thiazolopyrimidinderivate
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
DE69331739D1 (de) Neuartige pharmazeutische verwendungen von krill-enzymen
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
MX9601994A (es) Profarmacos de derivados de paclitaxel.
CA2152771A1 (en) 7-o-ethers of taxane derivatives
SE9802937D0 (sv) Novel compounds
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
NZ217356A (en) Benzamide derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee